nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—AR—scrotum—retroperitoneal cancer	0.762	0.762	CbGeAlD
Bicalutamide—AR—kidney—retroperitoneal cancer	0.0541	0.0541	CbGeAlD
Bicalutamide—AR—adrenal gland—retroperitoneal cancer	0.0437	0.0437	CbGeAlD
Bicalutamide—AR—testis—retroperitoneal cancer	0.0362	0.0362	CbGeAlD
Bicalutamide—CYP3A4—kidney—retroperitoneal cancer	0.0296	0.0296	CbGeAlD
Bicalutamide—CYP2D6—kidney—retroperitoneal cancer	0.0292	0.0292	CbGeAlD
Bicalutamide—AR—lymph node—retroperitoneal cancer	0.0262	0.0262	CbGeAlD
Bicalutamide—CYP2D6—testis—retroperitoneal cancer	0.0195	0.0195	CbGeAlD
